Moreover, the increased sensitivity of the diagnostic assays for KIT D816V variant is expected to improve the diagnostic algorithm in SM, especially in patients with equivocal symptoms, allowing to spare invasive procedures such as bone marrow biopsy. The gene discussed is KIT; the disease is systemic mastocytosis.